Home >> Signaling Pathways >> DNA Damage/DNA Repair

DNA Damage/DNA Repair

Products for  DNA Damage/DNA Repair

  1. Cat.No. Product Name Information
  2. GC38000 β-Boswellic acid A pentacyclic triterpene with diverse bioactivities β-Boswellic acid  Chemical Structure
  3. GC31365 γ-Oryzanol γ-Oryzanol is a potent DNA methyltransferases (DNMTs) inhibitor in the striatum of mice. γ-Oryzanol  Chemical Structure
  4. GC38194 (±)-10-Hydroxycamptothecin (±)-10-Hydroxycamptothecin is an indole alkaloid that inhibits the activity of topoisomerase I and has a broad spectrum of anticancer activity. (±)-10-Hydroxycamptothecin  Chemical Structure
  5. GC33107 (±)-BAY-1251152

    (±)-BAY-1251152; (±)-VIP152

    (±)-BAY-1251152 ((±)-BAY-1251152) is a racemic mixture of BAY-1251152. BAY-1251152 is a potent and highly selective PTEF/CDK9 inhibitor. (±)-BAY-1251152  Chemical Structure
  6. GC10867 (+)-Aphidicolin

    ICI 69653, NSC 234714

    Aphidicolin ((+)-Aphidicolin), a reversible inhibitor of eukaryotic nuclear DNA replication, can block the cell cycle at the pre-S phase. (+)-Aphidicolin  Chemical Structure
  7. GC34955 (+)-CBI-CDPI1 (+)-CBI-CDPI1 is an enhanced functional analog of CC-1065. (+)-CBI-CDPI1 is a DNA alkylating agent. (+)-CBI-CDPI1 is an antibody drug conjugates (ADCs) toxin. (+)-CBI-CDPI1  Chemical Structure
  8. GC34956 (+)-CBI-CDPI2 (+)-CBI-CDPI2 is an enhanced functional analog of CC-1065. (+)-CBI-CDPI1 is a DNA alkylating agent. (+)-CBI-CDPI2 is an antibody drug conjugates (ADCs) toxin. (+)-CBI-CDPI2  Chemical Structure
  9. GC32429 (-)-BAY-1251152

    (-)-BAY-1251152; (-)-VIP152

    (-)-BAY-1251152 ((-)-BAY-1251152) is an enanthiomer of BAY-1251152 with rotation (-). BAY-1251152 is a potent and highly selective PTEF/CDK9 inhibitor. (-)-BAY-1251152  Chemical Structure
  10. GC48635 (-)-Cryptopleurine

    (R)-Cryptopleurine, NSC 19912

    An alkaloid with diverse biological activities (-)-Cryptopleurine  Chemical Structure
  11. GC40076 (-)-Voacangarine

    NSC 306219, (-)-Voacristine

    (-)-Voacangarine is an indole alkaloid originally isolated from V. (-)-Voacangarine  Chemical Structure
  12. GC38377 (2S,3R)-Voruciclib hydrochloride (2S,3R)-Voruciclib hydrochloride is the enantiomer of Voruciclib hydrochloride. (2S,3R)-Voruciclib is an orally active CDK inhibitor. (2S,3R)-Voruciclib hydrochloride  Chemical Structure
  13. GC41695 (6R,S)-5,6,7,8-Tetrahydrofolic Acid (hydrochloride)

    Tetrahydrofolate, THFA

    (6R,S)-5,6,7,8-Tetrahydrofolic acid (THFA), the reduced form of folic acid, serves as a cofactor in methyltransferase reactions and is the major one-carbon carrier in one carbon metabolism. (6R,S)-5,6,7,8-Tetrahydrofolic Acid (hydrochloride)  Chemical Structure
  14. GC41088 (6S)-Tetrahydrofolic Acid (6S)-Tetrahydrofolic acid is a diastereomer of tetrahydrofolic acid, a reduced form of folic acid that serves as a cofactor in methyltransferase reactions and is the major one-carbon carrier in one carbon metabolism. (6S)-Tetrahydrofolic Acid  Chemical Structure
  15. GC62735 (E/Z)-GO289 (E/Z)-GO289 is a potent and selective casein kinase 2 (CK2) inhibitor (IC50=7 nM). (E/Z)-GO289 strongly lengthens circadian period. (E/Z)-GO289 exhibits cell type–dependent inhibition of cancer cell growth that correlated with cellular clock function. (E/Z)-GO289  Chemical Structure
  16. GC64429 (E/Z)-Zotiraciclib citrate

    (E/Z)-TG02 citrate; (E/Z)-SB1317 citrate

    (E/Z)-Zotiraciclib citrate is a potent CDK2, JAK2, and FLT3 inhibitor. (E/Z)-Zotiraciclib citrate  Chemical Structure
  17. GC63864 (E/Z)-Zotiraciclib hydrochloride

    (E/Z)-TG02 hydrochloride; (E/Z)-SB1317 hydrochloride

    (E/Z)-Zotiraciclib ((E/Z)-TG02) hydrochloride is a potent CDK2, JAK2, and FLT3 inhibitor. (E/Z)-Zotiraciclib hydrochloride  Chemical Structure
  18. GC69793 (R)-5-O-Benzoyl-1,2-di-O-isopropylidene-alpha-D-xylofuranose

    (R)-5-O-Benzoyl-1,2-di-O-isopropylidene-alpha-D-xylofuranose is a purine nucleoside analogue. Purine nucleoside analogues have broad anti-tumor activity and target inert lymphoid malignancies. The anticancer mechanism in this process depends on inhibiting DNA synthesis, inducing apoptosis (cell death), etc.

    (R)-5-O-Benzoyl-1,2-di-O-isopropylidene-alpha-D-xylofuranose  Chemical Structure
  19. GC41716 (R)-CR8 Cyclin-dependent kinases (CDKs) are key regulators of cell cycle progression and are therefore promising targets for cancer therapy. (R)-CR8  Chemical Structure
  20. GC39281 (R)-CR8 trihydrochloride

    CR8, (R)-Isomer trihydrochloride

    (R)-CR8 (CR8) trihydrochloride, a second-generation analog of Roscovitine, is a potent CDK1/2/5/7/9 inhibitor. (R)-CR8 trihydrochloride  Chemical Structure
  21. GC64210 (R)-GSK-3685032 (R)-GSK-3685032 is the R-enantiomer of GSK-3685032. GSK-3685032 is a non-time-dependent, noncovalently, first-in-class reversible DNMT1-selective inhibitor, with an IC50 of 0.036 μM. GSK-3685032 induces robust loss of DNA methylation, transcriptional activation, and cancer cell growth inhibition. (R)-GSK-3685032  Chemical Structure
  22. GC41633 (R)-Prunasin (R)-Prunasin is a inhibitor of DNA Polymerase β. (R)-Prunasin  Chemical Structure
  23. GC34124 (rel)-MC180295

    (rel)-MC180295

    (rel)-MC180295 ((rel)-(rel)-MC180295) is a potent and selective CDK9-Cyclin T1 inhibitor, with an IC50 of 5 nM, at least 22-fold more selective for CDK9 over other CDKs. (rel)-MC180295 also inhibits GSK-3α and GSK-3β. (rel)-MC180295 ((rel)-(rel)-MC180295) has potent anti-tumor effect. (rel)-MC180295  Chemical Structure
  24. GC10098 (S)-10-Hydroxycamptothecin

    ChEMBL 273862, NSC 107124

    inhibitor of topoisomerase I (S)-10-Hydroxycamptothecin  Chemical Structure
  25. GC34999 (S)-Ceralasertib

    (S)-AZD6738

    (S)-Ceralasertib ((S)-AZD6738) is extracted from patent WO2011154737A1, Compound II, exhibits an IC50 of 2.578 nM.(S)-Ceralasertib is a potent and selective sulfoximine morpholinopyrimidine ATR inhibitor with excellent preclinical physicochemical and pharmacokinetic (PK) characteristics.(S)-Ceralasertib is developed improving aqueous solubility and eliminates CYP3A4 time-dependent inhibition. (S)-Ceralasertib  Chemical Structure
  26. GC46351 (S)-CR8 An inhibitor of cyclin-dependent kinases (S)-CR8  Chemical Structure
  27. GC13136 (S)-Crizotinib Potent MTH1 inhibitor (S)-Crizotinib  Chemical Structure
  28. GC65877 (S)-GFB-12811 (S)-GFB-12811 (compound 596) is a potent and selective CDK5 inhibitor, with an IC50 value less than 10 nM. (S)-GFB-12811 can be used in the research of cell cycle progression, neuronal development, tumorigenesis. (S)-GFB-12811  Chemical Structure
  29. GC65997 (S)-LY3177833 hydrate (S)-LY3177833 ((S)-Example 2) hydrate is an orally active CDC7 kinase inhibitor. (S)-LY3177833 hydrate shows broad in vitro anticancer activity. (S)-LY3177833 hydrate  Chemical Structure
  30. GC60421 (S)-Seco-Duocarmycin SA (S)-Seco-Duocarmycin SA is a DNA alkylator, cytotoxic to cancer cells, and acts as a ADC cytotoxin for antibody-drug conjugates. (S)-Seco-Duocarmycin SA  Chemical Structure
  31. GC39842 (Z)-4EGI-1 (Z)-4EGI-1 is the Z-isomer of 4EGI-1 and is an inhibitor of eIF4E/eIF4G interaction and of translation initiation. (Z)-4EGI-1 effectively binds to eIF4E with an IC50 of 43.5 μM and a Kd value of 8.74 μM. (Z)-4EGI-1 has anticancer activity. (Z)-4EGI-1  Chemical Structure
  32. GC68484 1,2-O-Isopropylidene-5-O-p-toluoyl-a-D-xylofuranose

    1,2-O-Isopropylidene-5-O-p-toluoyl-a-D-xylofuranose is a purine nucleoside analogue. Purine nucleoside analogues have broad anti-tumor activity and target malignant tumors in the inert lymphatic system. The anticancer mechanism in this process depends on inhibiting DNA synthesis, inducing apoptosis (cell death), etc.

    1,2-O-Isopropylidene-5-O-p-toluoyl-a-D-xylofuranose  Chemical Structure
  33. GC19528 1,4-Benzoquinone

    p-Benzoquinone, NSC 36324, p-Quinone

    A toxic metabolite of benzene 1,4-Benzoquinone  Chemical Structure
  34. GC41859 1,5,7-Triazabicyclo[4.4.0]dec-5-ene

    TBD, Triazabicyclodecene

    1,5,7-Triazabicyclo[4.4.0]dec-5-ene is a bicyclic guanidine base that can be used as a catalyst for a variety of base-mediated organic transformations, including Michael additions, Wittig reactions, Henry reactions, and transesterification reactions. 1,5,7-Triazabicyclo[4.4.0]dec-5-ene  Chemical Structure
  35. GC65551 1-(2'-O-4-C-Methylene-beta-D-ribofuranosyl)thymine 1-(2'-O-4-C-Methylene-beta-D-ribofuranosyl)thymine is a bicyclic nucleoside. 1-(2'-O-4-C-Methylene-beta-D-ribofuranosyl)thymine  Chemical Structure
  36. GC49470 1-Ethyl-1-nitrosourea (hydrate)

    ENU, Ethylnitrosourea, N-Ethyl-N-nitrosourea, N-Nitroso-N-ethylurea

    A DNA alkylating agent 1-Ethyl-1-nitrosourea (hydrate)  Chemical Structure
  37. GC48909 1-Hydroxyanthraquinone

    NSC 8640

    An anthraquinone with genotoxic and carcinogenic activities 1-Hydroxyanthraquinone  Chemical Structure
  38. GC65038 1-Methylinosine

    1-methyl Inosine, N1-Methylinosine

    1-Methylinosine is a modified nucleotide found at position 37 in tRNA 3' to the anticodon of eukaryotic tRNA. 1-Methylinosine  Chemical Structure
  39. GC49872 10-Formyltetrahydrofolate (sodium salt) (technical grade)

    10-CHO-FH4, 10-CHO-THF, N10-Formyltetrahydrofolate, 10-formyl H4PteGlu, 10-fTHF

    10-Formyltetrahydrofolate (sodium salt) (technical grade) is a form of tetrahydrofolic acid that acts as a donor of formyl groups in anabolism. 10-Formyltetrahydrofolate (sodium salt) (technical grade)  Chemical Structure
  40. GC63796 116-9e

    MAL2-11B

    116-9e (MAL2-11B) is a Hsp70 co-chaperone DNAJA1 inhibitor. 116-9e  Chemical Structure
  41. GC49759 13C17-Mycophenolic Acid

    13C17-MPA

    An internal standard for the quantification of mycophenolic acid 13C17-Mycophenolic Acid  Chemical Structure
  42. GC46474 18-Deoxyherboxidiene

    RQN-18690A

    A bacterial metabolite with antiangiogenic activity 18-Deoxyherboxidiene  Chemical Structure
  43. GC65489 2'-F-Bz-dC Phosphoramidite 2'-F-Bz-dC Phosphoramidite can be used in the synthesis of oligoribonucleotides. 2'-F-Bz-dC Phosphoramidite  Chemical Structure
  44. GC66651 2'-O,4'-C-Methyleneadenosine

    LNA-A

    2'-O,4'-C-Methyleneadenosine (LNA-A) is a locked nucleic acid (LNA) and is also an adenosine analog. 2'-O,4'-C-Methyleneadenosine  Chemical Structure
  45. GC66654 2'-O,4'-C-Methylenecytidine

    LNA-C(Bz)

    2'-O,4'-C-Methylenecytidine (LNA-C(Bz)) is a bicyclic nucleoside analogue with fixed N-type conformation. 2'-O,4'-C-Methylenecytidine can be used to synthesize oligonucleotides. 2'-O,4'-C-Methylenecytidine forms duplexes with complementary DNA and RNA strands. 2'-O,4'-C-Methylenecytidine  Chemical Structure
  46. GC66655 2'-O,4'-C-Methyleneguanosine

    LNA-G

    2′-O,4′-C-Methyleneguanosine (LNA-G) is a reverse guanine analogue, where LNA (locked nucleic acid) is a nucleic acid analogue. LNA modification can be used in a variety of applications such as effective binding affinity to complementary sequences and greater nuclease resistance than natural nucleotides, offering great potential for applications in disease diagnosis and research. LNA-G is also available via KOD DNA polymerase, which allows the integration of LNA-G nucleotides into the DNA strand. 2'-O,4'-C-Methyleneguanosine  Chemical Structure
  47. GC52183 2'-O-Methyl-5-methyluridine

    2'-O-Methylribothymidine, 2'-O-Methylthymidine

    2'-O-Methyl-5-methyluridine  Chemical Structure
  48. GC66713 2'-O-MOE-5-Me-C(Bz) 2'-O-MOE-5-Me-C (Bz) is a nucleotide for the stereoselective synthesis of nucleoside alkyl phosphonates. 2'-O-MOE-5-Me-C(Bz)  Chemical Structure
  49. GC66657 2'-O-MOE-5-Me-rC 2'-O-MOE-5-Me-rC is an active compound. 2'-O-MOE-5-Me-rC can be used for oligonucleotide synthesis. 2'-O-MOE-5-Me-rC  Chemical Structure
  50. GC66091 2'-O-MOE-5-Me-rU 2'-O-MOE-5-Me-rU is an active compound. 2'-O-MOE-5-Me-rU can be used for oligonucleotide synthesis. 2'-O-MOE-5-Me-rU  Chemical Structure
  51. GC66656 2'-O-MOE-rC 2'-O-MOE-rC is a 2'-O-MOE modified nucleoside. 2'-O-MOE-rC can be used for synthesis of DNA. 2'-O-MOE-rC  Chemical Structure
  52. GC66652 2'-O-MOE-U 2'-O-MOE-U is a phosphoramidite, can be used for oligonucleotide synthesis. 2'-O-MOE-U  Chemical Structure
  53. GC65170 2′,3′-Di-O-acetylguanosine 2′,3′-Di-O-acetylguanosine is a nucleoside analog. 2′,3′-Di-O-acetylguanosine  Chemical Structure
  54. GC67384 2′-Deoxy-β-L-uridine 2'-Deoxy-β-L-uridine is a nucledside analogue and a specific substrate for the viral enzyme, shows no stereospecificity against herpes simplex 1 (HSV1) thymidine kinase (TK). 2′-Deoxy-β-L-uridine exerts antiviral activity via the interation of 5'-triphosphates with the viral DNA polymerase. 2′-Deoxy-β-L-uridine  Chemical Structure
  55. GC61667 2′-Deoxy-2′-fluoroadenosine 2′-Deoxy-2′-fluoroadenosine can be used for thesynthesisof 2′-Deoxy-2′-fluoro-modified oligonucleotides hybridized with RNA. 2′-Deoxy-2′-fluoroadenosine can be cleaved efficiently by E. coli purine nucleoside phosphorylase (PNP) to the toxic agent 2-fluoroadenine (FAde). 2′-Deoxy-2′-fluoroadenosine shows excellent in vivo activity against tumors expressing E. coli PNP. 2′-Deoxy-2′-fluoroadenosine  Chemical Structure
  56. GC62530 2’-O-Me-C(Bz) Phosphoramidite 2’-O-Me-C(Bz) Phosphoramidite is a modified phosphoramidite monomer, which can be used for the oligonucleotide synthesis. 2’-O-Me-C(Bz) Phosphoramidite  Chemical Structure
  57. GC62529 2’-OMe-A(Bz) Phosphoramidite 2’-OMe-A(Bz) Phosphoramidite is a modified phosphoramidite monomer, which can be used for the oligonucleotide synthesis. 2’-OMe-A(Bz) Phosphoramidite  Chemical Structure
  58. GC62531 2’-OMe-G(ibu) Phosphoramidite 2’-OMe-G(ibu) Phosphoramidite is a modified phosphoramidite monomer, which can be used for the oligonucleotide synthesis. 2’-OMe-G(ibu) Phosphoramidite  Chemical Structure
  59. GC46508 2',2'-Difluoro-2'-deoxyuridine

    dFdU

    An active metabolite of gemcitabine 2',2'-Difluoro-2'-deoxyuridine  Chemical Structure
  60. GC42061 2',3'-Dideoxyadenosine 5'-triphosphate

    2',3'-Dideoxyadenosine 5'-triphosphate

    2',3'-Dideoxyadenosine 5'-triphosphate (2',3'-Dideoxyadenosine 5'-triphosphate), an active metabolite of 2',3'-dideoxyinosine, is a chain-elongating inhibitor of DNA polymerase. 2',3'-Dideoxyadenosine 5'-triphosphate  Chemical Structure
  61. GC46519 2',3'-O-Isopropylideneguanosine A building block 2',3'-O-Isopropylideneguanosine  Chemical Structure
  62. GC46540 2'-Deoxyadenosine-5'-triphosphate (sodium salt hydrate) A purine nucleotide 2'-Deoxyadenosine-5'-triphosphate (sodium salt hydrate)  Chemical Structure
  63. GC48440 2'-Deoxycytidine-5'-triphosphate (sodium salt)

    dCTP

    2'-Deoxycytidine-5'-triphosphate (sodium salt) (dCTP trisodium salt) is a nucleoside triphosphate that can be used for DNA synthesis. 2'-Deoxycytidine-5'-triphosphate (sodium salt)  Chemical Structure
  64. GC42151 2'-Deoxyguanosine 5'-monophosphate (sodium salt hydrate)

    dGMP

    2'-Deoxyguanosine 5'-monophosphate (dGMP) is used as a substrate of guanylate kinases to generate dGDP, which in turn is phosphorylated to dGTP, a nucleotide precursor used in DNA synthesis. 2'-Deoxyguanosine 5'-monophosphate (sodium salt hydrate)  Chemical Structure
  65. GC33430 2'-Deoxypseudoisocytidine 2'-Deoxypseudoisocytidine is a nucleoside analogue. 2'-Deoxypseudoisocytidine  Chemical Structure
  66. GC35072 2'-O,4'-C-Methyleneuridine 2'-O,4'-C-Methyleneuridine (Compound 15a) is a bicyclic nucleoside. 2'-O,4'-C-Methyleneuridine  Chemical Structure
  67. GC42080 2'2'-cGAMP (sodium salt)

    Adenosine-Guanosine 2’,2’-cyclic monophosphate, cGAMP(2’-5’), 2’,2’-Cyclic GMP-AMP

    2'2'-cGAMP is a synthetic dinucleotide (CDN) that contains non-canonical 2'5'-phosphodiester bonds. 2'2'-cGAMP (sodium salt)  Chemical Structure
  68. GC64399 2,4,6-Trihydroxybenzoic acid 2,4,6-Trihydroxybenzoic acid, the flavonoid metabolite, is a CDK inhibitor. 2,4,6-Trihydroxybenzoic acid can be used for the research of cancer. 2,4,6-Trihydroxybenzoic acid  Chemical Structure
  69. GC60459 2,4-D (2,4-Dichlorophenoxyacetic acid)

    2,4D, Diclordon, Vidon 638

    2,4-D (2,4-Dichlorophenoxyacetic acid) (2,4-D (2,4-Dichlorophenoxyacetic acid) ichlorophenoxyacetic acid) is a selective systemic herbicide for the control of broad-leaved weeds. 2,4-D (2,4-Dichlorophenoxyacetic acid)   Chemical Structure
  70. GC46524 2,6-Dichloropurine-9-β-D-riboside

    2,6-Dichloropurine riboside

    A building block

    2,6-Dichloropurine-9-β-D-riboside  Chemical Structure
  71. GC33496 2-(Methylamino)-1H-purin-6(7H)-one (N2-methylguanine) 2-(Methylamino)-1H-purin-6(7H)-one (N2-methylguanine) (N2-Methylguanine) is a modified nucleoside. 2-(Methylamino)-1H-purin-6(7H)-one (N2-methylguanine)  Chemical Structure
  72. GC64983 2-Amino-2'-deoxyadenosine 2-Amino-2'-deoxyadenosine is a deoxyribonucleoside used for the oligonucleotide synthesis. 2-Amino-2'-deoxyadenosine  Chemical Structure
  73. GC39527 2-O-Methylcytosine 2-O-Methylcytosine, an O-alkylated analogue a DNA adduct, is the damaged nucleobase. 2-O-Methylcytosine  Chemical Structure
  74. GC49348 2-Thiocytidine

    α-2-Thioribocytidine

    A modified nucleobase 2-Thiocytidine  Chemical Structure
  75. GC42197 2-Thiouridine

    1-β-D-ribofuranosyl-2-thiouracil, s2U

    2-Thiouridine (s2U) is a modified nucleobase found in tRNAs that is known to stabilize U:A pairs and modestly destabilize U:G wobble pairs. 2-Thiouridine  Chemical Structure
  76. GC65083 3'-Azido-3'-deoxy-5-fluorocytidine 3'-Azido-3'-deoxy-5-fluorocytidine (Compound 12) is a cytidine derivative. 3'-Azido-3'-deoxy-5-fluorocytidine  Chemical Structure
  77. GC64985 3'-O-Methylguanosine 3'-O-Methylguanosine is a methylated nucleoside analogs and a RNA chain terminator. 3'-O-Methylguanosine  Chemical Structure
  78. GC68542 3'Ome-m7GpppAmpG ammonium

    3'Ome-m7GpppAmpG ammonium is a trinucleotide cap analog containing locked nucleic acid (LNA) molecules. It has significant translation efficiency and can be used as a potential molecular biology tool in the fields of mRNA vaccines and mRNA transfection, such as protein production, gene therapy, and anti-cancer immunity.

    3'Ome-m7GpppAmpG ammonium  Chemical Structure
  79. GC40618 3',4',7-Trihydroxyisoflavone

    3'-hydroxy Daidzein, 3’,4’,7-THIF

    3',4',7-Trihydroxyisoflavone, a major metabolite of Daidzein, is an ATP-competitive inhibitor of Cot (Tpl2/MAP3K8) and MKK4. 3',4',7-Trihydroxyisoflavone has anticancer, anti-angiogenic, chemoprotective, and free radical scavenging activities. 3',4',7-Trihydroxyisoflavone  Chemical Structure
  80. GC35105 3'-Azido-3'-deoxy-beta-L-uridine 3'-Azido-3'-deoxy-beta-L-uridine (Compound 25) is a nucleoside derivative. 3'-Azido-3'-deoxy-beta-L-uridine  Chemical Structure
  81. GC60023 3'-Deoxyuridine-5'-triphosphate

    3'-dUTP

    3'-Deoxyuridine-5'-triphosphate (3'-dUTP) is a nucleotide analogue that inhibits DNA-dependent RNA polymerases I and II. 3'-Deoxyuridine-5'-triphosphate  Chemical Structure
  82. GC61862 3'-Deoxyuridine-5'-triphosphate trisodium

    3'-dUTP trisodium

    3'-Deoxyuridine-5'-triphosphate trisodium (3'-dUTP trisodium) is a nucleotide analogue that inhibits DNA-dependent RNA polymerases I and II. 3'-Deoxyuridine-5'-triphosphate trisodium  Chemical Structure
  83. GC45332 3'-Dephosphocoenzyme A

    depCoA, Dephospho-CoA

    An intermediate in the biosynthesis of CoA 3'-Dephosphocoenzyme A  Chemical Structure
  84. GC34384 3,6-DMAD hydrochloride 3,6-DMAD hydrochloride, an acridine derivative, is a potent IRE1α-XBP1s pathway inhibitor. 3,6-DMAD hydrochloride promotes IL-6 secretion via the IRE1α-XBP1s pathway. 3,6-DMAD hydrochloride inhibits IRE1α oligomerization and endoribonuclease (RNase) activity. 3,6-DMAD hydrochloride can be used for research of cancer. 3,6-DMAD hydrochloride  Chemical Structure
  85. GC34452 3,7,4'-Trihydroxyflavone 3,7,4'-Trihydroxyflavone, isolated from Rhus javanica var. 3,7,4'-Trihydroxyflavone  Chemical Structure
  86. GC52129 3-Amino-5-hydroxybenzoic Acid

    AHBA

    3-Amino-5-hydroxybenzoic Acid  Chemical Structure
  87. GC13510 3-AP

    3-Aminopyridine-2-Carboxyaldehyde Thiosemicarbazone,NSC 663249,Triapine™

    ribonucleotide reductase inhibitor and iron chelator with antitumor activity 3-AP  Chemical Structure
  88. GC48457 3-keto Fusidic Acid

    3-keto FA, 3-Oxofusidic Acid

    An active metabolite of fusidic acid 3-keto Fusidic Acid  Chemical Structure
  89. GC65084 3-Methylcytidine 3-Methylcytidine, a urinary nucleoside, can be used as a biomarker of four different types of cancer: lung cancer, gastric cancer, colon cancer, and breast cancer. 3-Methylcytidine  Chemical Structure
  90. GC52391 306-O12B-3 An ionizable cationic lipidoid 306-O12B-3  Chemical Structure
  91. GC15389 360A 360A  Chemical Structure
  92. GC10115 360A iodide 360A iodide  Chemical Structure
  93. GC14493 4μ8C

    4u8C

    IRE1 Rnase inhibitor, potent and non-toxic

    4μ8C  Chemical Structure
  94. GC17271 4'-Demethylepipodophyllotoxin

    (-)-4′-Demethylepipodophyllotoxin

    An inhibitor of tubulin polymerization 4'-Demethylepipodophyllotoxin  Chemical Structure
  95. GC46607 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone

    NNK

    A tobacco-specific nitrosamine carcinogen 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone  Chemical Structure
  96. GC11761 4-amino-1,8-Naphthalimide

    4-Aminonaphthalimide,4-ANI

    4-amino-1,8-Naphthalimide is a potent PARP inhibitor and potentiates the cytotoxicity of γ-radiation in cancer cells. 4-amino-1,8-Naphthalimide  Chemical Structure
  97. GC42401 4-hydroperoxy Cyclophosphamide

    4-OOH-CY

    An activated analog of cyclophosphamide 4-hydroperoxy Cyclophosphamide  Chemical Structure
  98. GC68332 4-Hydroperoxy Cyclophosphamide-d4 4-Hydroperoxy Cyclophosphamide-d4  Chemical Structure
  99. GC18853 4-isocyanato TEMPO 4-isocyanato TEMPO is a spin labeling reagent used to label the 2'-position in RNA. 4-isocyanato TEMPO  Chemical Structure
  100. GC61683 4-Methoxyphenethyl alcohol 4-Methoxyphenethyl alcohol, an aromatic alcohol, is the major component in the anise-like odour produced by A. 4-Methoxyphenethyl alcohol  Chemical Structure
  101. GC49127 4-oxo Cyclophosphamide

    4-keto CP, 4-keto Cyclophosphamide, NSC 139488, 4-oxo CP

    An inactive metabolite of cyclophosphamide 4-oxo Cyclophosphamide  Chemical Structure

Items 1 to 100 of 1391 total

per page
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Set Descending Direction